Tests a phone app based on cognitive behavioral therapy for depression
Tests a phone app of talk-therapy exercises in people aged 14 to 60 with depression.
Plain-language title generated from the registry record
Registry title: Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study
Key facts
- Where
- Beijing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 14 and 60 years old?
Source: NCT06831435, who can take part
Where in China
- Peking University Sixth HostipalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Peking University
- Trial code
- NCT06831435
- Record updated
- 15 December 2025
- Original description
The project proposes to develop a digital product based on cognitive behavioral therapy for the assisted treatment of depression. The digital cognitive behavioral therapy in this study is conducted based on a self-developed mobile applet. The therapy is developed by psychotherapists, which is conducted for a total of 8 weeks, with weekly sessions including AI-guided course work and homework. This study aims to evaluate the therapeutic effects of CBT-based digital products for depression in patients through a real-world study, and to explore its genetic and neuroimaging mechanisms.Read full original descriptionShow less
Effectiveness of Digital Cognitive Behavioral Therapy for the Treatment of Depression: a Real-world Study
The project proposes to develop a digital product based on cognitive behavioral therapy for the assisted treatment of depression. The digital cognitive behavioral therapy in this study is conducted based on a self-developed mobile applet. The therapy is developed by psychotherapists, which is conducted for a total of 8 weeks, with weekly sessions including AI-guided course work and homework. This study aims to evaluate the therapeutic effects of CBT-based digital products for depression in patients through a real-world study, and to explore its genetic and neuroimaging mechanisms.
Inclusion: Aged 14-60 years (including 14 and 60), no gender restriction; HAMD >= 14; Written informed consent obtained from the patient; written informed consent obtained from the guardian for minors.
Exclusion: Persons with severe suicidal tendencies (item 10 of the MADRS scale ≥ 5).